Home Visit
Upload
.png)
BRCA1/BRCA2 Comprehensive (Sequencing And Deletion/Duplication) in Mulund
51+ booked in last 3 days
No special precautions
Sample Type
Blood
Recommended for
Female
Blood test at Home
NABL & CAP Accredited Labs
Accurate & Quality Test Reports
Trusted by Leading Doctors & Hospitals
Overview
BRCA stands for Breast Cancer gene. BRCA1 and BRCA2 genes play a crucial role in preventing cancer, in your body. These genes are also called as tumor suppressor genes. BRCA1 and BRCA2 play a role in DNA repair and prevent breast, ovarian and other types of cells from growing uncontrollably. Mutations in these genes can increase the risk of breast and ovarian cancers. This test identifies such mutations, helping to understand your inherited cancer risk.
BRCA1/BRCA2 Comprehensive (Sequencing And Deletion/Duplication) Price in Mulund
Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the BRCA1/BRCA2 Comprehensive (Sequencing And Deletion/Duplication) with a clear pricing structure
The price of BRCA1/BRCA2 Comprehensive (Sequencing And Deletion/Duplication) in Mulund is ₹ 30,000
We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.
Frequently Asked Questions
The assay detect mutation and large deletion / duplication in BRCA1 and BRCA2 gene.
As suggested by doctor to test in Individuals With Strong Family History of Breast or Ovarian Cancer (HBOC).
Test ordered in Individuals With Strong Family History of Breast or Ovarian Cancer (HBOC). The assay detect mutation in BRCA1 and BRCA2 gene. Evaluation for patients with a personal or family history suggestive of hereditary breast and ovarian cancer (HBOC) syndrome. Establishing a diagnosis of HBOC syndrome allowing for targeted cancer surveillance based on associated risks. Identifying variants within genes known to be associated with increased risk for HBOC syndrome allowing for predictive testing of at-risk family members. Therapeutic eligibility including poly adenosine diphosphate-ribose polymerase (PARP) inhibitors in select cancer types.
Ratings & Reviews (0)
Why Metropolis?
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.
WhatsApp